Article

Allogeneic stem cell transplantation for myelofibrosis in the modern era: single- center outcomes with DIPSS risk stratification

2026-03-19

Abstract excerpt

<title>Abstract</title> <p>Background To describe post-transplant outcomes in patients with myelofibrosis stratified by the Dynamic International Prognostic Scoring System (DIPSS) risk at transplantation, and to identify clinical factors associated with overall survival (OS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods We retrospectively analyzed 42 patients with myelofibrosis w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1dfbfc69-e233-5507-882f-a325a6aacf0f
DOI: 10.21203/rs.3.rs-9039701/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Allogeneic stem cell transplantation for myelofibrosis in the modern era: single- center outcomes with DIPSS risk stratificationDOI 10.21203/rs.3.rs-9039701/v1Read

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisSemantic proximity Read

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Semantic proximity Read

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.Semantic proximity Read

Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.Semantic proximity Read

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and BelgiumSemantic proximity Read

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.Semantic proximity Read

Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosisSemantic proximity Read

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantationSemantic proximity Read

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real-life perspective.Semantic proximity Read

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationSemantic proximity Read

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-MSemantic proximity Read

Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information.Semantic proximity Read